Jaye L. Thompson
Chief Tech/Sci/R&D Officer at GREENWICH LIFESCIENCES, INC.
Net worth: 3 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Rothe | M | 49 | 18 years | |
| Snehal Patel | M | 60 | 14 years | |
| David McWilliams | M | 80 | 15 years | |
| F. Daugherty | M | 73 | 5 years | |
| Kenneth Hallock | M | 75 | 5 years | |
| Christine T. Fischette | M | - | 3 years | |
| Fernando Martinez | M | - |
inVentiv Clinical Solutions LLC
| 16 years |
| Walter Ulrich | M | - |
Gulf Coast Regional Center of Innovation & Commercialization
| - |
| Joachim F. Wernicke | M | 76 | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joseph S. Podolski | M | 76 | 28 years | |
| Larry Dillaha | M | 60 | 1 years | |
| Jean L. Fourcroy | M | 93 | 9 years | |
| David Hung | M | 67 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 years |
| Patrick P. Fourteau | M | 77 | 2 years | |
| Gail Maderis | F | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 6 years |
| Michael Wyllie | M | 73 | 7 years | |
| Donald Healey | M | 62 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 7 years |
| Kenny S. Frazier | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Sona Saira Ramasastry | F | 48 | 5 years | |
| Mark Lappe | M | 57 | 1 years | |
| Ronald D. Wiehle | M | 75 | 19 years | |
| Karthik Radhakrishnan | M | 53 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 years |
| Donald Tredway | M | - | - | |
| Michael Suesserman | M | 59 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 24 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jaye L. Thompson
- Personal Network
